These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29742314)

  • 1. Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease.
    Goyal D; Kaur A; Goyal B
    ChemMedChem; 2018 Jul; 13(13):1275-1299. PubMed ID: 29742314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.
    Zha X; Lamba D; Zhang L; Lou Y; Xu C; Kang D; Chen L; Xu Y; Zhang L; De Simone A; Samez S; Pesaresi A; Stojan J; Lopez MG; Egea J; Andrisano V; Bartolini M
    J Med Chem; 2016 Jan; 59(1):114-31. PubMed ID: 26632651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S; Kettle C; Morton DW
    Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzofuran-chalcone hybrids as potential multifunctional agents against Alzheimer's disease: synthesis and in vivo studies with transgenic Caenorhabditis elegans.
    Sashidhara KV; Modukuri RK; Jadiya P; Dodda RP; Kumar M; Sridhar B; Kumar V; Haque R; Siddiqi MI; Nazir A
    ChemMedChem; 2014 Dec; 9(12):2671-84. PubMed ID: 25251917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease.
    Mesiti F; Chavarria D; Gaspar A; Alcaro S; Borges F
    Eur J Med Chem; 2019 Nov; 181():111572. PubMed ID: 31404859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer's disease agents.
    Yun Y; Miao Y; Sun X; Sun J; Wang X
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1346-1356. PubMed ID: 34134572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From anti-allergic to anti-Alzheimer's: Molecular pharmacology of Dimebon.
    Okun I; Tkachenko SE; Khvat A; Mitkin O; Kazey V; Ivachtchenko AV
    Curr Alzheimer Res; 2010 Mar; 7(2):97-112. PubMed ID: 19939222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in Alzheimer's disease drug discovery: an update.
    Williams M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uleine Disrupts Key Enzymatic and Non-Enzymatic Biomarkers that Leads to Alzheimer's Disease.
    Seidl C; de Moraes Santos CA; De Simone A; Bartolini M; Weffort-Santos AM; Andrisano V
    Curr Alzheimer Res; 2017; 14(3):317-326. PubMed ID: 27784218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery strategies for Alzheimer's disease treatment.
    Di Stefano A; Iannitelli A; Laserra S; Sozio P
    Expert Opin Drug Deliv; 2011 May; 8(5):581-603. PubMed ID: 21391862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents.
    George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S
    Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
    Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
    Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
    J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
    León R; Garcia AG; Marco-Contelles J
    Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?
    Ehret MJ; Chamberlin KW
    Clin Ther; 2015 Aug; 37(8):1604-16. PubMed ID: 26122885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitarget Directed Ligand Approaches for Alzheimer's Disease: A Comprehensive Review.
    Ramalakshmi N; R S R; C N N
    Mini Rev Med Chem; 2021; 21(16):2361-2388. PubMed ID: 33820504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.